We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

625 hedge funds and large institutions have $11.2B invested in Exact Sciences in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 239 increasing their positions, 206 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 239 | Existing positions reduced: 206

0.55% less ownership

Funds ownership: 90.97%90.42% (-0.55%)

6% less call options, than puts

Call options by funds: $127M | Put options by funds: $134M

4% less funds holding

Funds holding: 654625 (-29)

27% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 86

27% less capital invested

Capital invested by funds: $15.3B → $11.2B (-$4.09B)

50% less funds holding in top 10

Funds holding in top 10: 126 (-6)

Holders
625
Holders Change
-29
Holders Change %
-4.43%
% of All Funds
9.92%
Holding in Top 10
6
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-50%
% of All Funds
0.1%
New
63
Increased
239
Reduced
206
Closed
86
Calls
$127M
Puts
$134M
Net Calls
-$7.44M
Net Calls Change
-$13.7M

EXAS Hedge Fund Activity: Q3 2023 in Review

625 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2023, worth a combined $11.2B — down 27% from $15.3B a quarter earlier.

Sellers outnumbered buyers: 86 funds closed out of EXAS and 63 opened new positions — a net loss of 23 holders — while 206 trimmed existing stakes and 239 added.

The largest buyer was JP Morgan Chase, adding an estimated $279M. The largest seller was Marshall Wace, exiting entirely with an estimated $91.6M sold.

  • 625 institutional investors held Exact Sciences (EXAS) as of Q3 2023, down from 654 in Q2 2023.
  • Funds reported $11.2B of Exact Sciences stock for Q3 2023, down 27% quarter-over-quarter.
  • 63 funds opened new Exact Sciences positions in Q3 2023 and 86 closed out, a net change of -23 holders.
  • The largest Exact Sciences buyer in Q3 2023 was JP Morgan Chase, an estimated $279M added.
  • The largest Exact Sciences seller in Q3 2023 was Marshall Wace, an estimated $91.6M sold.

Based on aggregated 13F filings for Q3 2023.